A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial Infection

Musculoskeletal Diseases Clinical Trial

Official title:
A Multicenter, Long-Term, Active-Surveillance Study of Musculoskeletal Disorders That Occur After Initiating a Course of Levofloxacin (RWJ-25213-097) or Non-Fluoroquinolone Therapy for Acute Infectious Diseases in Children Who Were Enrolled in Phase 3 Clinical Trials Involving Levofloxacin Therapy

Status Completed

Clinical Trial Summary

The purpose of this study is to assess the long-term safety of levofloxacin administered to children as therapy for acute bacterial infection.

Clinical Trial Description

This is a prospective (look forward using periodic observations collected predominantly following participant enrollment), long-term, comparative, multicenter, observational study (study in which the investigators/physicians observe the participants and measure their outcomes) to monitor long-term the incidence of musculoskeletal (MS) disorders in children who have received levofloxacin or a standard therapy for acute bacterial infection. Approximately 2500 participants who were enrolled in prior Phase 3 clinical studies of the use of levofloxacin for the treatment of acute infectious disease will be observed in this study. The study consists of 3 phases: a screening phase; a surveillance phase; and a musculoskeletal disorder follow-up phase. Safety evaluations will include assessment of an overall incidence of musculoskeletal disorders that occur during the first 60 days after the first dose of anti-microbial therapy. The specific musculoskeletal disorders to be reported are: tendinopathy (inflammation or rupture of a tendon); arthritis (inflammation of a joint as shown by redness or swelling); arthralgia (pain in a joint); gait abnormality (limping or refusal to walk). Other assessments of safety will include interviews using standardized questionnaires to assess the occurrence of musculoskeletal adverse events, physical examinations, and measurement of participants height over the course of 1 year. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00210639
Study type	Observational
Source	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Contact
Status	Completed
Phase	Phase 3
Start date	August 2002
Completion date	May 2010

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT04976972` - A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation	N/A
Recruiting	`NCT05546541` - Epidemiology and Nutrition
Completed	`NCT05071469` - Comparison of Two Different Treatment Methods	N/A
Completed	`NCT05041400` - Distribution of Knee Isokinetic Angle-specific Moments and Ratios	N/A
Not yet recruiting	`NCT06216028` - Bone Marrow Aspirate Concentrate (BMAC) Treatment for Knee Osteoarthritis	Phase 3
Not yet recruiting	`NCT04932993` - Writing Down Goals	N/A
Completed	`NCT02944448` - A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee	Phase 2
Completed	`NCT02256098` - RSA RCT: ATTUNE™ TKA Versus PFC Sigma TKA	N/A
Completed	`NCT02257489` - Phase 1 Study of ACE-083 in Healthy Subjects	Phase 1
Completed	`NCT02269254` - Persona Versus NexGen	N/A
Completed	`NCT01979731` - Effects Job Rotation in the Prevention of Work Related Musculoskeletal Disorders	N/A
Active, not recruiting	`NCT01440153` - Additional Exercise Program in Professional Dancers	N/A
Completed	`NCT00968266` - Improving Beliefs About Medication in Patients With Rheumatoid Arthritis	N/A
Completed	`NCT05222126` - Efficacy of Ultrasound-Guided Hydrodissection in Carpal Tunnel Syndrome	N/A
Completed	`NCT05062694` - Physical Therapy Management Of The Patient With Central Sensitization
Recruiting	`NCT05564182` - High Intensity Laser Therapy in the Treatment of Hemiplegic Shoulder Pain	N/A
Completed	`NCT04009369` - Impacts of Physiotherapy Services in a Quebec Emergency Department	N/A
Completed	`NCT05561452` - The Efficacy of PRP Injection in the Treatment of Rotator Cuff Syndrome	N/A
Recruiting	`NCT05432609` - Standardization and Reproducibility Regarding Scanning Procedures and Measurements of Weight-bearing Cone Beam CT in the Lower Extremity
Completed	`NCT04959162` - The Effect of Theoretical Knowledge on Resident's Practical Performance in Musculoskeletal Ultrasound	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.